SCHEMBL4909587

SCHEMBL4909587

COc1cccc2c(NC(=O)Nc3ccc(N(CCCl)CCCl)cc3)c3cccc(C(=O)O)c3nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.42
HPSE Q9Y251 2/20 0.41
PDE10A Q9Y233 1/20 0.41
HIF1A Q16665 3/20 0.40
IDO1 P14902 1/20 0.40
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39
NPC1 O15118 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RAB9A P51151 2/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4935599 0.91 EGFR (0.40) KDM1AHPSEHIF1AEGFRERBB2
SCHEMBL4902270 0.90 KDM1A (0.42) KDM1APDE10AIDO1NPC1ALDH1A1
SCHEMBL4908994 0.90 KDM1A (0.55) KDM1AHPSEHIF1AEGFRERBB2
SCHEMBL4908894 0.89 KDM1A (0.43) KDM1APDE10AIDO1PARP1
SCHEMBL4909277 0.89 IDO1 (0.44) KDM1AIDO1ALDH1A1MEN1KMT2A
SCHEMBL4912880 0.88 ABL1 (0.42) KDM1AIDO1
SCHEMBL4912315 0.88 KDM1A (0.42) KDM1AIDO1ALDH1A1MAPTKDM4E
SCHEMBL4913140 0.88 KDM1A (0.42) KDM1AHPSEPDE10AIDO1ALDH1A1
SCHEMBL4909655 0.87 EGFR (0.41) KDM1AHPSEIDO1EGFRERBB2
SCHEMBL4904734 0.85 EGFR (0.45) KDM1AEGFRERBB2NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080171765-A1 Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents ACADEMIA SINICA (TW) 2008-07-17 US claimed
US-8222297-B2 e.g. 1-[3-(acridin-9-ylamino)-5-hydroxymethylphenyl]-3-{4-[bis(2-chloroethyl)amino]phenyl}urea; anticarcinogenic agent; improved chemical stability and efficacy; brain tumor, breast cancer, colon cancer, leukemia, and neuroblastoma ACADEMIA SINICA (TW) 2012-07-17 US disclosed
US-20080171765-A1 Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents ACADEMIA SINICA (TW) 2008-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171765-A1 Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents WEE1, PCNA, ATIC KDM1A 722/4885HPSE 1280/4885PDE10A 2925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.